Consolidation in US hurts Indian generic firms Dr Reddy’s Lab, Sun Pharma | The Indian Express
0
The consolidation of pharmaceutical supply chains in the US, by which wholesale and retail drug suppliers have teamed up to procure generic medicines, is starting to hurt revenues of Indian generics players, whose sales come mainly from the US market.
Abhijit Mukherjee, COO, Dr Reddy’s Laboratories, told analysts on a call recently, “Without giving you exact figures, I think this has been one of the most brutal years of price erosion as channel consolidation has been heavy in the US.”
Read more – The Indian Express